New Delhi, April 9 Glenmark Pharmaceuticals announced on Thursday that it has received final approval from the US health regulator for its generic version of progesterone vaginal inserts used in fertility treatments.The approval from the US Food and Drug Administration (USFDA) is for 100 mg...
bioequivalence
drug approval
endometrin
fertility treatments
generic pharmaceuticals
glenmark pharmaceuticals
medical devices
north america
pharmaceuticalsales
progesterone vaginal inserts
therapeutic equivalence
us food and drug administration (usfda)
us market
vaginal inserts
women's healthcare
New Delhi, February 27 Glenmark Pharmaceuticals announced on Friday that its US-based unit is preparing to introduce a generic sodium phosphate injection in the American market.The Mumbai-based pharmaceutical company stated that its product is therapeutically equivalent to Hosira Inc.'s...
New Delhi, February 25 Drug firm Lupin announced on Wednesday that it has received approval from the US health regulator to market a generic medication to treat seizures.The Mumbai-based firm has received approval from the USFDA for its abbreviated new drug application (ANDA) for Brivaracetam...
anda
brivaracetam
briviact
bse
drug approval
generic medication
india
lupin
oral solution
pharmaceutical industry
pharmaceuticalsales
seizures
us market
usfda